Corning Showcases 3D Cell Culture Technologies at SLAS 2018
Pharmaceutical Technology's In the Lab eNewsletter
Corning will feature its 3D bioprinting technology and tools to support 3D cell culture at booth #1029 during the SLAS 2018 conference on Feb. 3-7, 2018 in San Diego, CA.
Corning, a material sciences engineering and manufacturing firm, will showcase its advanced, high-throughput 3D cell culture technologies and workflow solutions at the Society for Laboratory Automation and Screening (SLAS) conference in San Diego, CA, on Feb. 3-7, 2018, the company announced on Jan. 18, 2018.
The company will also showcase its lab automation, drug screening, and cancer research technologies. It will feature its 3D bioprinting technology as well as new dissolvable microcarriers that facilitate high-volume cell expansion and the high-speed, automated CytoSmart cell counter.
The company and its customers will also hold a number of presentations and poster sessions at the conference describing high-throughput screening using 3D cell culture, including:
Sunday, Feb. 4, 2018
Short course: Set-up and Validation of 3D Primary, Stem Cell and Immortalized Cultures for Downstream Microplate Reader and Imaging Applications
8:00-11:15 a.m.
Monday, Feb. 5, 2018
Tutorial: 3D Image-Based Characterization of 3D Cell Culture Models Generated Using Spheroid Microplates.
2:00-2:45 p.m.
Tuesday, Feb. 6, 2018
Podium talk: Development of 3-Dimensional Human Cortical Spheroid Platforms with High Homogeneity and Functionality for High Throughput and High Content Screening
11:00-11:30 a.m.
Podium talk: An Ultra High Throughput 3D Assay Platform for Evaluating T-cell-Mediated Tumor Killing
12:00-12:30 p.m.
Tutorial: Hepatotoxicity Determination Using 3D Primary Human Hepatocyte Culture Systems versus Large Approved Drug Libraries
2:00-2:45 p.m.
Exhibitor spotlight: Rock the Science of 3D: From Promise to Reality
4:00-4:20 p.m.
Wednesday, Feb. 7, 2018
Podium talk: High Throughput 3D Assays
11:00-11:30 a.m.
Posters
Monday, Feb. 5, 2018
A Novel Three-Dimensional Glioma Blood Brain Barrier Model for High Throughput Testing of Tumoricidal Capability
5:00-6:00 p.m. Poster Presentation 1106-B
Combination of Ultra-Low Attachment Spheroid Microplates with a Tissue Clearing Technique for Easy-to-Use 3D Cell Culturing and True 3D Characterization
5:00-6:00 p.m. Poster Presentation 1036-B
3D High Content Screening of Liver Spheroids
5:00-6:00 p.m. Poster Presentation 1121-B
Source: Corning
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
